Find a Doctor - Search by last name or narrow your search by gender or languages spoken
Find a Location - Search by specialty, city, or state
Corticosteroids (such as prednisone or dexamethasone) are referred to as "transitional" medicines for the treatment of cluster headaches, because they are sometimes used to break a cycle of cluster headaches. They are paired with medicines that stop (abortive) or prevent (prophylactic) additional headaches during a headache cycle. Often, within 2 to 4 days after starting treatment with corticosteroids, you will become headache-free. By the time the corticosteroids are stopped—their use is often tapered within 6 to 8 weeks of starting and then discontinued—the medicines used to prevent cluster headaches, such as verapamil, have taken effect.
Corticosteroids are not used over a long period of time because they can cause serious side effects, including:
See Drug Reference for a full list of side effects. (Drug Reference is not available in all systems.)
| By | Healthwise Staff |
|---|---|
| Primary Medical Reviewer | Anne C. Poinier, MD - Internal Medicine |
| Specialist Medical Reviewer | Colin Chalk, MD, CM, FRCPC - Neurology |
| Last Revised | January 27, 2012 |
Next Section:
Related InformationPrevious Section:
Topic OverviewNext Section:
CreditsPrevious Section:
Related InformationLast Revised: January 27, 2012
Author: Healthwise Staff
Medical Review: Anne C. Poinier, MD - Internal Medicine & Colin Chalk, MD, CM, FRCPC - Neurology
This information does not replace the advice of a doctor. Healthwise, Incorporated disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. How this information was developed to help you make better health decisions.
To learn more visit Healthwise.org
© 1995-2012 Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.
RT @drdavidpearce: Early trigger for #alzheimers http://t.co/aQnGFDHYnT reported might be a target for #neurodegenerative & #rarediseases